Evaluation of fish models of soluble epoxide hydrolase inhibition. by Newman, J W et al.
Environmental Health Perspectives • VOLUME 109 | NUMBER 1 | January 2001 61
Evaluation of Fish Models of Soluble Epoxide Hydrolase Inhibition
John W. Newman,1 Debra L. Denton,2 Christophe Morisseau,1 Cory S. Koger,3 Craig E. Wheelock,1 David E.
Hinton,3 and Bruce D. Hammock1,4
1Department of Entomology, 2Department of Land, Air, and Water Resources, and 3Department of Anatomy, Physiology, and Cell
Biology, University of California, Davis, California, USA; 4University of California Davis Cancer Center, Sacramento, California, USA
Chemicals containing urea, carbamate, and
amide moieties flanked by hydrophobic
residues can be potent in vitro and in vivo
inhibitors of mammalian soluble epoxide
hydrolases (sEH; EC 3.3.2.3) (1). Several
pesticides contain these structures. Soluble
epoxide hydrolase is a highly conserved,
ubiquitous enzyme that hydrolyzes aliphatic
epoxides to their corresponding vicinal diols
(2). The identification of lipid epoxides as
endogenous sEH substrates (3-5) suggests a
central role for this enzyme in cellular ion
balance, vascular permeability, and inflam-
mation (6-9) in addition to its role in xenobi-
otic metabolism. Therefore, sEH inhibition
by environmental contaminants or therapeu-
tics may present a subtle yet pertinent health
risk. A model system allowing in vivo effects
of sEH inhibition to be rapidly evaluated
could accelerate identification of such risks
while assisting research into the endogenous
role of this enzyme. Additionally, the investi-
gation of sEH as a therapeutic target could
benefit from a cost-efficient, rapid in vivo
sEH inhibition model.
It is well recognized that metabolic trans-
formations can alter the relative potency of
bioactive molecules when assessed under in
vivo versus in vitro scenarios. Unfortunately,
the cost of rigorous in vivo toxicity testing in
rodent models often prohibits comprehen-
sive mammalian testing. Alternative in vivo
models may provide invaluable tools for pri-
oritizing further studies in mammalian sys-
tems. A precursor model would use easily
reared and handled organisms that have a
complement of drug-metabolizing enzymes
and the biochemical target of toxicant
action. Fish models of mammalian responses
to toxicants exist for investigations of car-
cinogenicity (10), oxidative stress (11), and
immunotoxicity (12). Among the beneﬁts of
these ﬁsh models are the ease of husbandry,
the potential for large experimental sample
sizes with increased statistical power, the
ability to investigate early developmental life
stages, and the similarity between mam-
malian and piscine xenobiotic metabolizing
enzymes.
We assessed two larval and embryo/larval
fish models for the investigation of xenobi-
otic interactions with soluble epoxide
hydrolase. Considerable quantities of sEH
have been shown in the liver, kidney, and
gill of the rainbow trout (Salmo gairdneri)
(13). In addition, gender-specific and tem-
poral changes in epoxy and dihydroxy
eicosatrienoic acids reported in the marine
scup (Stenotomus chrysops) (14) suggest a
dynamic physiological role for sEH in teleost
species. The functional conservation of sEH
between mammals and fish was first
evaluated by investigating the in vitro sEH
inhibition capacity of the chemicals listed in
Table 1 with appropriate sEH orthologs.
Further, two phenyl urea herbicides, diuron
(II) and siduron (VI) were selected as model
in vivo toxicants and evaluated in both larval
fathead minnow (Pimphales promelas) and
embryo/larval golden medaka (Oryzias
latipes) assays. In the medaka, sublethal toxi-
city end points were investigated as markers
of developmental toxicity linked to sEH
inhibition in vivo. Further, we assess the util-
ity of these ﬁsh models to investigate in vivo
versus in vitro sEH inhibitor potency.
Materials and Methods
Chemicals. Compounds listed in Table 1
were either purchased or synthesized in our
laboratory. Compounds were purchased at
> 99% purity from ChemServices Inc.
(Philadelphia, PA; II, VI, VII, and VIII) and
Thompson Hayward (Kansas City, KS; V) or
> 98% purity from Chevron Chemical Co.
(Richmond, CA; IX and XI) and Stauffer
Chemical Co. (Richmond, CA; X). The
diuron (II) used had less than 0.05% of bis-
3,4-dichloro-phenyl urea (IV) by weight as
determined by HPLC analysis (1). Siduron
(VI) was a technical mixture of positional
methyl cyclohexyl isomers. The trans-stilbene
oxide (TSO) was purchased from Aldrich
Chemical Co. (Milwaukee, WI). The cis-stil-
bene oxide ([3H]-CSO), [3H]-trans-diphenyl
propene oxide ([3H]-tDPPO), and racemic
4-nitrophenyl-trans-2,3-epoxy-3-phenyl-
propyl carbonate (NEPC) were previously
synthesized in our laboratory (15–17).
Chemical stock solutions for enzyme assays
and in vivo exposures were prepared in either
dimethyl formamide (Aldrich) or methanol
(Optima grade; Fisher Scientiﬁc, Pittsburgh,
PA), respectively.
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Articles
Substituted ureas and carbamates are mechanistic inhibitors of the soluble epoxide hydrolase
(sEH). We screened a set of chemicals containing these functionalities in larval fathead minnow
(Pimphales promelas) and embryo/larval golden medaka (Oryzias latipes) models to evaluate the
utility of these systems for investigating sEH inhibition in vivo. Both fathead minnow and
medaka sEHs were functionally similar to the tested mammalian orthologs (murine and human)
with respect to substrate hydrolysis and inhibitor susceptibility. Low lethality was observed in
either larval or embryonic fish exposed to diuron [N-(3,4-dichlorophenyl), N´-dimethyl urea],
desmethyl diuron [N-(3,4-dichlorophenyl), N´-methyl urea], or siduron [N-(1-methylcyclohexyl),
N´-phenyl urea]. Dose-dependent inhibition of sEH was a sublethal effect of substituted urea
exposure with the potency of siduron < desmethyl diuron = diuron, differing from the observed
in vitro sEH inhibition potency of siduron > desmethyl diuron > diuron. Further, siduron expo-
sure synergized the toxicity of trans-stilbene oxide in fathead minnows. Medaka embryos exposed
to diuron, desmethyl diuron, or siduron displayed dose-dependent delays in hatch, and elevated
concentrations of diuron and desmethyl diuron produced developmental toxicity. The dose-
dependent toxicity and in vivo sEH inhibition correlated, suggesting a potential, albeit undeﬁned,
relationship between these factors. Additionally, the observed inversion of in vitro to in vivo
potency suggests that these ﬁsh models may provide tools for investigating the in vivo stability of
in vitro inhibitors while screening for untoward effects. Key words: epoxide hydrolase, fish, in
vivo models, mammals, urea pesticides. Environ Health Perspect 109:61–66 (2001). [Online 13
December 2000]
http://ehpnet1.niehs.nih.gov/docs/2001/109p61-66newman/abstract.htmlWe synthesized ureas I, III, and IV by
mixing isocyanates with corresponding
amines and isolated them by recrystallization.
Structural confirmation and purity assess-
ments were made by melting-point (mp)
determinations, proton nuclear mass reso-
nance (NMR), and mass spectral analyses.
The syntheses of compounds I (mp
103.5–104°C) and III (mp 155–156°C) have
been previously reported (1,18). Compound
IV was synthesized by adding a 10% molar
excess of 3,4-dichloro amine (Aldrich) to 3,4-
dichlorophenyl isocyanate dissolved in chloro-
form. Crystallization was promoted by hexane
addition. Crystals were isolated by ﬁltration
and further puriﬁed by recrystallization from
n-hexane. The isolated product displayed a
349 Da molecular ion under positive mode
electrospray ionization on a Quattro-BQ
(Fisons, Altrancham, England) and exhibited
a decomposition point of 270–271°C. Proton
NMR on a QE-300 (General Electric Co.,
Fairfield, CT) provided complete proton
assignments: 2 1HAromatic - d (7.743 ppm; J =
8.9 Hz), 2 1HAromatic - d (7.928 ppm; J = 9.0
Hz), 2 1HAromatic - s (8.263 ppm), 2 1HUrea - s
(9.535 ppm).
Test organisms. Larval fathead minnows
(7 days old) were purchased from Aquatox
(Hot Springs, AR) and acclimated for 24 hr
in aerated test water (see “Exposure water
preparation and handling”). Golden medaka
embryos were obtained from our colony
maintained at the University of California
Davis, Institute of Ecology. Embryonated egg
masses were separated by rolling them
between moistened ﬁngertips; then they were
rinsed in 25 mg/L NaCl and aerated vigor-
ously to prevent fungal infections. We iso-
lated embryos in early to late blastula stage
(20–24 hr postfertilization) under a dissecting
scope for exposures. The care and treatment
of fish were in accordance with UC Davis
animal use protocols 7357 and 8450 for fat-
head minnow and medaka, respectively.
Fish protein preparations. We pooled
either 150 fathead minnows (7 days old) or
125 medaka (21–28 days old) for initial
enzyme assays. Pooled larvae were rinsed with
water, transferred to polyethylene vials, ﬂash
frozen in liquid nitrogen, and stored at
–80°C. Frozen larvae were subsequently
thawed and homogenized with a 1-mL glass
homogenizer in amended phosphate buffer
[0.1 M, pH 7.4 with 1 mM each of phenyl
methyl sulfonyl ﬂuoride (PMSF), disodium
ethylenediamine tetracetate, and dithiothre-
itol]. Homogenates were centrifuged at 9,000
g at 4°C for 10 min. Supernatants were sub-
aliquoted and stored at –80° C. Subsequently,
aliquots were thawed for the assessment of
total protein content and selected enzyme
activities. We quantified total protein 
concentrations using the bicinchonic acid
assay (Pierce, Rockford, IL) with fraction V
bovine serum albumin (Sigma Chemical Co.,
St. Louis, MO) as the calibrating compound.
Mammalian soluble epoxide hydrolase
preparations. Recombinant mouse and
human sEH were expressed and purified as
previously reported using a baculovirus expres-
sion system and affinity chromatography
(19–21). The preparations were at least 97%
pure as judged by Coomassie blue-stained
sodium dodecyl sulfate polyacrylamide gel
electrophoresis and scanning densitometry.
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Table 1. Usage of selected urea, carbamate, and thiocarbamate pesticides.
Compound Chemical structure AI (kg) Common name (description)
I N-Cyclohexyl, N´-(3-phenyl) propyl urea
II 472,298 Diuron (herbicide)
III Desmethyl diuron (diuron metabolite)
IV 1–5%  Bis-dichlorophenyl urea (diuron impurity)
V 35,418 Diﬂubenzuron (insecticide)
VI 112 Siduron (herbicide)
VII 202a Chlorpropham (herbicide)
VIII 765 Fenoxycarb (insecticide)
IX 2,226,055 Molinate (herbicide)
X 412,325 Cycloate (herbicide)
XI 652,109 Thiobencarb (herbicide)
AI, active ingredient. Annual use data from the U.S. Geological Survey (35) unless otherwise noted.
aAnnual use data from the U.S. Department of Agriculture (36).
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NEnzyme assays. We assessed activity of
sEH using either a radiometric assay with
[3H]-tDPPO (16) or a spectrophotometric
assay employing NEPC (17) for puriﬁed and
crude protein preparations, respectively.
Unlike NEPC, [3H]-tDPPO allows determi-
nation of sEH activity in the presence of
active esterases and glutathione-S-transferases
(16). Glutathione conjugates of [3H]-tDPPO
were not detected in crude preparations.
Microsomal epoxide hydrolase (mEH) activ-
ity was determined using [3H]-CSO as
previously described (13). To determine com-
pound concentrations that inhibited diol for-
mation by 50% (IC50), protein preparations
were preincubated with potential inhibitors
(Table 1) for 5 min at 30°C before reporting
substrate addition. Fathead minnow, mouse,
and human enzyme dilutions (1 nmol diol
formed/min/mg of total protein) were assayed
in triplicate with 10-min incubations.
Medaka enzyme (0.4 nmol/min/mg) assays
were run in duplicate with 15-min incuba-
tions due to limited enzyme availability. IC50
values were determined by linear regression
(r2 > 0.97) of the percent inhibition with
respect to the log-transformed inhibitor con-
centration using values between 20 and 80%
inhibition. The curve was generated from at
least three separate runs to obtain the stan-
dard deviations in Table 2.
Exposure water preparation and han-
dling. All tests were conducted in moderately
hard water (i.e., test water) as deﬁned by the
U.S. Environmental Protection Agency. Test
water met described pH, dissolved oxygen,
and conductivity criteria (22). Sufﬁcient vol-
umes of test water containing diluted chemi-
cals (i.e., exposure water) were prepared
within 8 hr of initial organism exposure. For
static renewal experiments, excess exposure
water was stored at 4°C until use. Renewal
aliquots were brought to assay temperature
daily within 4 hr of solution renewal. We
prepared exposure levels as independent dilu-
tions of methanolic stock solutions, with
ﬁnal methanol concentrations not exceeding
0.05%. We achieved siduron concentrations
of 5 mg/L or greater by elevating mixture
temperature to 85°C with stirring to dissolve
the compound and then reducing the tem-
perature before use. For dual exposures,
matched trans-stilbene oxide exposures were
treated similarly. 
Fathead minnow acute toxicity tests.
Three replicates (n = 3) of 10 larval fathead
minnows (7 days old) were exposed for 96 hr
in 250 mL test water held at 20 ± 1°C. Larval
mortality was counted, general condition of
survivors was recorded, and 80% (200 mL) of
exposure water was replaced daily. Fish were
fed brine shrimp (Artemia sp.) daily 2 hr
before exposure water renewal. Exposure
water temperature, pH, dissolved oxygen con-
tent, and conductivity were recorded daily
and maintained in acceptable ranges accord-
ing to standard acute toxicity test methods
(22). Fathead minnows were exposed to com-
pound II (4.1, 8.2, 16, or 32 µM), compound
VI (5.4, 11, 22, 43, or 65 µM), or TSO (7.6,
13, 18, 24, or 28 µM). We repeated trans-stil-
bene oxide exposures in the presence of 40
µM compound VI. Concentrations causing
50% lethality (LC50) were calculated from
linear regressions of log-transformed concen-
tration-versus-mortality curves. In the case of
urea herbicide exposures, larval minnows sur-
viving at 96 hr within each exposure replicate
were prepared for enzyme assays as described
above. Linear regressions of log-transformed
data allowed the calculation of 50% effect
concentrations (EC50).
Medaka sEH activity and developmental
toxicity. To identify the developmental stage
of sEH appearance, pooled individuals (n =
18–25) were assayed at 2-day intervals
throughout development through 1 day
posthatch. We then measured sEH activity in
homogenized embryo/larval preparations as
described above. Toxicity tests were con-
ducted with five replicates (n = 5) of five
medaka embryos in early to late blastula stage
(20–24 hr postfertilization) in capped, acid-
washed, 20-mL borosilicate vials (Fisher
Scientiﬁc, Pittsburgh, PA) containing 2 mL
of exposure water, described above. Vehicle
and reconstituted water controls were
included for each exposure scenario (22). The
oxygen supply in a 2-mL static bath exposure
is sufﬁcient for embryos to complete normal
development (23,24). We inspected embryos
for mortality and developmental deformities at
24 ± 2 hr intervals using a dissecting scope.
Observations of gross morphologic alterations,
edematous changes, skeletal deformities,
abnormal hatching, and delayed hatching were
collected and used to calculate toxicity scores
as previously described (25). In initial experi-
ments exposing embryos to compound II
(4.1, 8.6, or 17 µM) or VI (22, 43, or 65
µM), hatched fry were transferred to clean
water at day 15 postexposure and observed for
4–5 days. We assessed larvae for viability and
the presence of persistent morphologic
changes, including swim bladder inflation
state. In subsequent experiments, 15 days pos-
texposure with 8.6, 35, or 65 µM of either
compound II or III, surviving embryos/larvae
were pooled (n = 17–20) and prepared for
sEH activity assays as described above. 
Statistics. We considered observations
statistically signiﬁcant if comparisons yielded
p-values < 0.05. Means were compared using
Student’s t-test. For medaka embryo/larval
results, differences from controls and
between treatments were assessed using a
Tukey-Kramer HSD test with the student
version of Minitab (Minitab Inc., State
College, PA).
Results
In vitro inhibition of sEH. The chemicals
listed in Table 1 were used to assess sEH
inhibition with the fathead minnow,
medaka, mouse, and human enzymes (Table
2). Both sEH reporting substrates (i.e.,
NEPC and [3H]-tDPPO) afforded the same
rank potency for compounds I, II, and IV
tested against the mouse enzyme, indicating
that these data can be compared. With [3H]-
tDPPO, the IC50 was 0.01 ± 0.003 µM, 0.5
± 0.1 µM, and 55 ± 5 µM for compounds I,
IV, and II, respectively. The radiolabeled
substrate [3H]-tDPPO was used to discrimi-
nate sEH from mEH inhibition in vitro (16),
while mEH activity was determined in the
presence of sEH by measuring [3H]-CSO
hydrolysis (13,26). The sEH inhibitors I, II,
III, and VI failed to inhibit mEH (IC50 >
500 µM), suggesting inhibitor speciﬁcity for
sEH, which agrees with our results in mam-
malian systems (1). Enzyme concentration
and enzyme affinity for the reporting sub-
strate are important factors affecting IC50
results; therefore, the IC50 values in Table 2
should not be directly compared between
species. However, the relative inhibition
potency for a given enzyme can be compared.
As seen in Table 2, potent urea inhibitors of
mammalian enzymes were potent inhibitors
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Table 2. Soluble epoxide hydrolase IC50 values for selected pesticides.
Compound Minnowa Medakab Mousec Humanc
I 0.014 ± 0.001 0.09 ± 0.01 0.06 ± 0.01 0.29 ± 0.01
II 78 ± 7 170 ± 30 120 ± 4 130 ± 6
III 5.5 ± 0.16 63 ± 8 110 ± 4 47 ± 2
IV 0.36 ± 0.01 1.3 ± 0.3 0.9 ± 0.1 1.5 ± 0.07
V > 500 > 500 270 ± 10 160 ± 10
VI 0.25 ± 0.01 1.0 ± 0.2 0.16 ± 0.02 0.36 ± 0.04
VII 130 ± 1 380 ± 62 210 ± 4 280 ± 10
VIII 97 ± 5 220 ± 10 110 ± 3 65 ± 4
IX 160 ± 20 460 ± 12 230 ± 20 130 ± 10
X 130 ± 2 260 ± 14 200 ± 15 82 ± 9
XI 350 ± 10 > 500 190 ± 10 40 ± 3
IC50 values are the means ± the SDs of three separate experiments at 30°C expressed in µM concentrations.
aIncubated 15 min with 50 µM tDPPO (3,000 dpm/assay). bIncubated 10 min with 50 µM tDPPO (3,000 dpm/assay).
cIncubated 1 min with 40 µM NEPC detected at ∆ 405nm (14 sec/scan).of ﬁsh enzymes (compounds I, IV, and VI).
Similarly, carbamates and thiocarbamates
were weak inhibitors in all tested species. In
general, the relative inhibitor strength of
chemicals within a given class (ureas: I–VI;
carbamates: VII and VIII; thiocarbamates:
IX–XI) were equivalent in all species with the
exception of thiobencarb (XI), which was
weaker in ﬁsh than in mammals. Among the
ureas, the inhibitor potency rank was compa-
rable except for desmethyl diuron (III). The
potency enhancement afforded by the N-
dealkylation of diuron (II) to III produced a
14-, 2.7-, 2.8-, and 1.1-fold increased potency
for the fathead minnow, medaka, human, and
mouse enzymes, respectively.
Fathead minnow toxicity and sEH activ-
ity. To determine if in vitro sEH inhibition
equated to in vivo inhibition, fathead min-
nows were exposed to increasing doses of two
model compounds, II and VI. Mortality due
to urea herbicide exposure was observed only
at 32 µM of compound II, which reached
70% by 96 hr (16 µM < LC50 < 32 µM).
Although compound VI did not produce lar-
val mortality, the highest exposure produced
behavioral effects. Control larvae feeding on
brine shrimp had a pronounced pink col-
oration of the gastrointestinal tract by 72 hr.
However, about 10% of the fry exposed to
64 µM compound VI were lethargic and had
clear gastrointestinal tracts, suggesting poor
food consumption. Larvae exposed to 40 µM
compound VI, however, were indistinguish-
able from controls at 96 hr. Split aliquots of
protein preparations from fathead minnows
surviving exposures of either compounds II
or VI were assayed for sEH activity and nor-
malized to sample protein content. Soluble
epoxide hydrolase activity exhibited dose-
dependent suppression under both exposure
scenarios (Figure 1). An EC50 of 12 µM and
28 µM was observed for compounds II and
VI, respectively. Because fish tissues were
diluted upon homogenization, and inhibition
of sEH with these competitive inhibitors is
rapidly reversible under such conditions (1),
the determined inhibition values should be
considered the lowest possible in vivo inhibi-
tion. It is also possible that the inhibition
measured in sample homogenates was due
either totally or partly to inhibitor accumu-
lated in vivo that gained access to sEH in situ
after sample homogenization. 
To verify that in vitro sEH inhibition
after exposure was an organismal event, not
an artifact of homogenization, we investi-
gated the dose-dependent toxicity of TSO in
the presence or absence of 40 µM compound
VI. trans-Stilbene oxide is a moderately 
reactive epoxide-containing molecule and
good surrogate substrate for soluble epoxide
hydrolase (27). Figure 2 displays larval mor-
tality results for exposures to compound VI
and TSO, either alone or in combination.
trans-Stilbene oxide induced a dose-depen-
dent acute toxicity in exposed fish, with an
apparent LC50 of 27 ± 3 µM. The addition
of 40 µM compound VI reduced the TSO
LC50 2.5-fold (Figure 2).
Medaka embryo/larval sEH activity and
developmental toxicity. Significant sEH
activity was observed from day 0 (stage 11, 1
day postfertilization; 2-fold over back-
ground), increased linearly with time (r2 =
0.98), and attained an 8-fold enhancement
at 1 day posthatch (11 days postfertiliza-
tion). To assess the potential effect of sEH
inhibitors on developing vertebrates, we
exposed medaka embryos to increasing con-
centrations of either compound II or VI.
Herbicide concentrations were selected to
avoid the acute toxic responses observed in
fathead minnows. Although morphologic
alterations were intermittently observed, sig-
niﬁcant delays in hatching time were noted
for compound II at 8.6 and 17 µM and at all
tested concentrations of compound VI
(Figure 3).
Embryo/larval assays were then con-
ducted with either compound II or its N-
demethylation product (compound III), the
primary metabolite of II in humans (28). At
the 8.6 µM exposures, hatch delays for larvae
exposed to compound II but not to com-
pound III were signiﬁcant (Figure 4); how-
ever, < 3% of the embryos failed to hatch
within 14 days. At exposures ≥ 32 µM,
delays in the time to embryonic hatch were
saturated (3.5 ± 0.9 day) for both com-
pounds II and III, and 20% of the embryos
failed to hatch within 15 days, yet retained a
visible heartbeat.
Developmental toxicity was dose depen-
dent and similar in embryos exposed to either
compound II or III (Figure 5). Similarly,
sEH activity was depressed in a dose-depen-
dent manner at hatch (II: r2 = 0.91; III: r2 =
0.80; 70 ± 14 % maximum inhibition), and
the EC50 for compounds II and III were not
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Figure 1. In vivo exposure to aryl ureas produced
in vitro sEH inhibition. Larval fathead minnows
were exposed to diuron (0–32 µM) and siduron
(0–65 µM) for 96 hr at 20°C. Survivors were pooled,
sEH activity was measured in triplicate, and the
means ± SDs were calculated. Diuron: r2 = 0.92;
EC50 = 12 µm. Siduron: r2 = 0.98; EC50 = 28 µm.
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Figure 2. Siduron exposure synergized trans-
stilbene oxide (TSO) toxicity in vivo. Larval fat-
head minnows were exposed to siduron (5–65
µM) and TSO (7.6–28 µM) with or without 40 µM
siduron for 96 hr. The potency of TSO measured
by larval mortality (LC50) was increased from 27 ±
3 µM to 11 ± 0.7 µM (p < 0.01) by siduron.
Figure 3. Medaka embryos exposed to diuron and
siduron displayed dose-dependent delays in time
to hatch. The difference in days to hatch between
exposed and 0.05% methanol control groups is
displayed as the means ± SEs. Day zero equals
initiation of exposure. Test water and methanol
control hatch times were 10 ± 0.3 and 9.7 ± 0.2
days, respectively.
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Figure 4. N-Demethylation of diuron reduced the
potency, but not the efficacy, of hatch delay.
Embryos were simultaneously collected and
exposed to diuron and desmethyl diuron. Hatch
delays were calculated as the difference in days
to hatch between exposed and 0.05% methanol
control groups. Day zero equals exposure initia-
tion. Test water and methanol control hatch times
were 10.1 ± 0.2 and 9.9 ± 0.6 days, respectively.
Results are reported as the means ± SEs (n = 5). 
*p < 0.05; **p < 0.001). 
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*statistically different. A single control
embryo died in one of ﬁve replicates during
this experiment, and no other control toxic-
ity was observed. The result was deemed
aberrant and excluded using a Q-test. At low
doses, toxicity scores were composed of
> 90% mild edematous injuries and minor
delays in hatch. Embryos exposed to ≥ 32
µM showed numerous morphologic changes
in ovo that persisted after hatching. At these
high doses, the swim bladders in all exposed
larvae failed to inflate, and 90% displayed
edema of the yolk sac. Increases of the dorsal
to ventral axis in exposed larvae constituted
additional evidence of edematous injury
(Figure 6). Inspection of morphologic alter-
ations, restricted here to those seen under a
dissecting scope, suggested alterations of the
gall bladder (dilation) and liver (increased
area). Previous correlated microscopic versus
dissecting scope investigations of medaka lar-
vae in our laboratory were the basis for
anatomical assignments at the organ level
(25). In the developing medaka, the gall
bladder is a single vacuole, on the left side of
the midline, bearing a transparent, yellow-
green appearance. In controls this structure
can be found at the caudal-most margin of
the liver (Figure 6). In exposed larvae this
structure was enlarged, forming a large, yel-
low-green vacuole in the abdominal cavity.
This gall bladder enlargement appeared in
ovo in all embryos exposed to ≥ 32 µM of
either compound II or III. This ﬁnding may
indicate excessive hepatic bile production or
dysfunction in the gall bladder mucosa,
impairing bile concentration normally
achieved by water removal.
Exposure to 65 µM of compound II or
III produced additional effects or lesions that
were more severe: apparent hepatomegaly
(i.e., enlargement of the liver; Figure 6),
mild to moderate pericardial edema, and
hatch failure and/or late stage embryonic
death. Pericardial edema brought the nor-
mally twisted and coiled heart tube (i.e., ini-
tial chamber formation) into a single
pulsatile tube and darkened the embryonic
vasculature, suggesting decreased blood ﬂow.
At 65 µM, edema-related changes in cardiac
morphology and severe delays in time to
hatch accounted for about 10% and about
25% of the total toxicity scores, respectively.
Skeletal abnormalities were rare (< 2%) and
showed a random distribution across doses.
The pronounced tilt of the head in exposed
fry was interpreted as a reflection of the
abdominal edema rather than as a skeletal
defect (Figure 6).
Discussion 
The primary goal of this study was to
evaluate two ﬁsh models as tools to investi-
gate the in vivo fate and effect of novel sEH
inhibitors. Ureas, carbamates, and amides
containing a protonated nitrogen alpha to a
carbonyl [i.e., R-NH(C = O)-R´] represent a
novel class of mechanistic sEH inhibitors (1).
Therefore, we compared the in vitro and in
vivo potency of a series of chemicals contain-
ing this pharmacophore, including a number
of pesticides and related compounds. In this
way, we made a preliminary risk assessment
of pesticide interactions with this biochemi-
cal target. We found that, like rainbow trout
(13), both fathead minnow and medaka sEH
were functionally similar to the tested mam-
malian orthologs with respect to substrate
hydrolysis and inhibitor susceptibility.
Three aryl ureas (compounds I, IV, and
VI) proved to be potent in vitro inhibitors
for all enzymes tested, whereas the screened
carbamates (VII and VIII) and thiocarba-
mates (IX–XI) were poor inhibitors. One
notable difference in observed potency was
for the mono-N-demethylation product of
compound II (i.e., compound III). With the
fathead minnow sEH, compound III was a
14-fold more potent inhibitor than com-
pound II, while the other tested orthologs
showed only a 2.2 ± 0.9-fold enhancement.
Because N-dealkylation is a dominant meta-
bolic transformation and degradation route
of many alkylureas (28–30), this ﬁnding sug-
gests that medaka may provide a better
model for mouse and human sEH inhibition
than fathead minnow.
Exposure to compounds II and VI pro-
duced little to no acute mortality in either
larval fathead minnows or embryonic
medaka. Similarly, a low incidence of late-
stage medaka embryo death was observed at
the highest concentration of compound III.
However, dose-dependent reductions in
sEH activity were induced by exposure to
compounds II, III, and VI in both ﬁsh mod-
els. Further, compound VI synergized trans-
stilbene oxide toxicity in co-exposed fathead
minnow larvae (Figure 2), conﬁrming the in
vitro suppression of sEH activity as an in
vivo effect. Although we attempted to assess
changes in sEH protein level as a source of
the reduced activity, available antibodies
against the mammalian sEH orthologs dis-
played weak cross reactivity with the fish
proteins (data not shown). Nevertheless,
these data clearly demonstrate that the tested
fish models can identify chemicals that
reduce in vivo sEH activity.
In fathead minnow larvae exposed for 96
hr, compound II reduced sEH activity more
than did compound VI, a reversal of the in
vitro IC50 results. In vitro inhibition describes
the relative inhibitor activity with a biochem-
ical target, while in vivo inhibitor behavior
integrates factors including chemical uptake,
distribution, and clearance. Therefore, the
shift of in vivo potency indicates that the
processes governing the fate and/or transport
of compounds II and VI in vivo are not
equivalent. Theoretically, either difference in
the physical chemical partitioning or meta-
bolic fate of these compounds could lead to
the observed discrepancy. The uptake of a
chemical from water by an organism can be
related to the log of the octanol:water
partitioning coefficient (log KOW) of that
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Figure 5. Medaka embryos exposed to either diuron
or desmethyl diuron displayed indistinguishable
dose-dependent developmental toxicity. Toxicity
scores were calculated as previously described
(25) and represent the means ± SDs of the sum of
ranked effects observed in each exposure replicate
(n = 5). Data that differed signiﬁcantly from control
values are noted (*p< 0.05; **p< 0.001).
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Figure 6. Morphologic observation of medaka lar-
vae. (A) Intact control. (B) 65 µM diuron (com-
pound II) exposed. (C) 65 µM desmethyl diuron
(compound III) exposed. Morphologic alterations
proved similar in both exposures. At 35 µM or
greater, gall bladder (g) enlargement was a com-
mon response [compare (A) vs. (B) and (C)]. The
gall bladder was identified by the yellow-green
coloration and stage of first appearance during
embryo development. The photographic ﬁlter used
to provide contrast improved structural deﬁnition
but obscured the distinct coloration. The dashed
line in (B) delineates the margin of the observed
coloration. The central dark mass was identified
as the liver (l) based on time of appearance in
development and position in larvae as described
in the text. Edematous injury to the pericardium
induced elongation of the heart (h) in a subset of
larvae exposed to 65 µM herbicide [compare (A)
and (B) vs. (C)]. Relative sizes can be estimated
using the ocular orbital height as reference.compound (31). The log KOW of compounds
II and VI are 2.58 and 3.09, respectively
(32). If solubility were driving the observed
in vivo differences, higher tissue concentra-
tions of compound VI would be expected.
However, based on the in vitro results, higher
concentrations of compound VI relative to
compound II should produce lower sEH
activity, rather than the observed increase.
Therefore, either sequestration of compound
VI into a non-sEH–containing compartment
occurs; or, alternatively, compounds II and VI
may exhibit different modes and/or time
dependence of metabolic clearance. Although
the metabolic transformation of compound II
has been described (28), similar information
for compound VI is lacking. Considering the
structure of compound VI, cytochrome P450-
dependent oxidation of either the phenyl ring
or the methyl cyclohexyl moiety would be
expected. Hydroxylation of either functional-
ity would signiﬁcantly reduce the hydrophobic
character of these side chains, a modiﬁcation
that dramatically reduces sEH inhibition
potency in a related series of compounds (33).
Therefore, metabolic activation of compound
II by N-demethylation and inactivation of
compound VI by side-chain hydroxylation
could explain the inversion of in vitro versus in
vivo potency, suggesting the presence of com-
petent xenobiotic metabolizing systems in the
exposed embryonic and larval ﬁsh.
Medaka embryos displayed toxicity; there-
fore, the semipermeable embryonic protein
coat, the chorion, did not prevent embryonic
exposure. Dose-dependent delays in hatch
were observed in exposures to both com-
pounds II and VI. As observed for the in vivo
sEH inhibition potency in fathead minnows,
compound II was a more potent inducer of
hatch delays. The severe developmental effects
at exposure concentrations of 65 µM (16
mg/L) of compound II compare well with
concentrations reported to cause frog embryo
developmental abnormalities and retardation
of tadpole growth (34). The inability to dis-
criminate either the toxicity or the in vivo sEH
inhibition potency of compound II from III
will require further investigations to elucidate
fully; however, they suggest metabolic trans-
formation of compound II occurs in vivo.
Speciﬁcally, compound II may be activated by
demethylation, or both compounds may be
transformed to a downstream toxic metabo-
lite, producing the similarity of the observed
organismal responses.
We have shown that extrapolating some
observations of sEH inhibition between
mammalian and teleost species is valid. The
presence of sEH activity in early life-stage
ﬁsh and their ability to modulate the potency
of sEH inhibitors supports their use as model
systems to identify discrepancies between in
vitro and in vivo sEH inhibition. Speciﬁcally,
postexposure sEH activity determinations
and/or shifts in trans-stilbene oxide toxicity
curves provide indices of in vivo sEH activity
suppression. Using these systems we have
identified diuron and desmethyl diuron as
weak in vivo sEH inhibitors. However, their
low potency indicates that the risk of sEH-
dependent untoward effects from environ-
mental diuron exposure is low. Nonetheless,
both depression of sEH activity and embryo
toxicity showed similar dose dependence,
suggesting a potential link between these fac-
tors. This ﬁnding further suggests that new
pesticides and therapeutics containing the
pharmacophores discussed here should be
evaluated as sEH inhibitors before they are
used commercially. 
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